Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Aplastic Anemia

Known as: Aplastic anemia NOS, ANEMIA, APLASTIC, Anemia, Aplastic [Disease/Finding] 
Anemia resulting from bone marrow failure (aplastic or hypoplastic bone marrow). The production of erythroblasts and red cells is markedly decreased… Expand
National Institutes of Health

Related topics

Related topics

41 relations

Broader (5)

AnemiaAplastic bone marrowMYELODYSPLASTIC SYNDROMEMyeloproliferative disease
Expand
Aplasia, NOSAregenerative anemiaBone Marrow DiseasesBone Marrow Transplantation
Expand

Narrower (6)

Aplastic anemia, idiopathicBone Marrow failure syndromesFanconi AnemiaPure Red-Cell Aplasia
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Horse versus rabbit antithymocyte globulin in acquired aplastic anemia.
BACKGROUND In severe acquired aplastic anemia, hematopoietic failure is the result of immune-mediated destruction of bone marrow… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
Review
2006
Review
2006
Current concepts in the pathophysiology and treatment of aplastic anemia.
Aplastic anemia, an unusual hematologic disease, is the paradigm of the human bone marrow failure syndromes. Almost universally… Expand
Highly Cited
2005
Highly Cited
2005
Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia.
BACKGROUND Mutations in TERC, the gene for the RNA component of telomerase, cause short telomeres in congenital aplastic anemia… Expand
  • table 1
  • table 2
  • figure 3
Highly Cited
2003
Highly Cited
2003
Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome.
CONTEXT In most patients, aplastic anemia results from T-cell-mediated immune destruction of bone marrow. Aplastic anemia can be… Expand
  • figure 1
  • figure 2
Highly Cited
2002
Highly Cited
2002
Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.
The incidence of postengraftment invasive aspergillosis (IA) in hematopoietic stem cell transplant (HSCT) recipients increased… Expand
  • table 1
  • figure 2
  • figure 1
  • figure 3
  • table 2
Review
2000
Review
2000
Progress with Light‐Emitting Polymers
Light-emitting polymers have been studied intensively as materials for light-emitting diodes (LEDs). Here research efforts toward… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Review
1997
Review
1997
The pathophysiology of acquired aplastic anemia.
Plastic anemia, which is pancytopenia with a fatty or “empty” bone marrow, is remarkable for the simplicity of its pathologic… Expand
Highly Cited
1996
Highly Cited
1996
Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients.
Risk factors for the development of a new (secondary) malignancy after marrow transplantation are still incompletely defined. In… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Highly Cited
1987
Highly Cited
1987
Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: a comparative histomorphometric study.
Retrospective histologic analyses of bone biopsies and of post mortem samples from normal persons of different age groups, and of… Expand
  • figure 1
  • table II
  • table I
  • table IV
  • table V
Highly Cited
1974
Highly Cited
1974
CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S
Sixty-one evaluable patients, 19 with advanced aplastic anemia and 42 with end stage hematological malignancies, were conditioned… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE